The other, a similar compound called pravastatin sodium, is manufactured by Bristol-Myers Squibb bmy (nyse: bmy - news - people) under the brand name Pravachol.
One large study of statins in people aged 70-82 years old found that illness and deaths from heart disease fell in those treated with pravastatin but overall there was no difference in mortality as rates of cancer illness and death increased.